Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

JD Kelly, AM Forster, B Higley, CM Archer… - Journal of nuclear …, 1993 - europepmc.org
A new cationic complex,[99mTc (tetrofosmin) 2O2]+, where tetrofosmin is the ether
functionalized diphosphine ligand 1, 2-bis [bis (2-ethoxyethyl) phosphino] ethane, has been …

[PDF][PDF] Development of nonreducible technetium-99m (III) cations as myocardial perfusion imaging agents: initial experience in humans

E Deutsch, JL Vanderheyden, P Gerundini… - Journal of nuclear …, 1987 - Soc Nuclear Med
MATERIALS AND METHODS General Unless otherwise specified, all materials were of
reagent grade. Solventsused in high performanceliquid chromatog raphy (HPLC) were …

[HTML][HTML] Technetium-99m radiopharmaceuticals for ideal myocardial perfusion imaging: Lost and found opportunities

A Boschi, L Uccelli, L Marvelli, C Cittanti, M Giganti… - Molecules, 2022 - mdpi.com
The favorable nuclear properties in combination with the rich coordination chemistry make
technetium-99m the radioisotope of choice for the development of myocardial perfusion …

Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin.

K Nakajima, J Taki, N Shuke, H Bunko… - Journal of Nuclear …, 1993 - europepmc.org
Technetium-99m tetrofosmin is a new myocardial perfusion imaging agent that accumulates
rapidly and shows slow clearance from the myocardium. Dynamic acquisition and SPECT …

Myocardial Perfusion Imaging With 99mTc Tetrofosmin: Comparison to 201Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial

BL Zaret, P Rigo, FJT Wackers, RC Hendel, SH Braat… - Circulation, 1995 - Am Heart Assoc
Background Our objective was to compare the sensitivity and specificity of tetrofosmin, a
new 99mTc-labeled myocardial perfusion imaging agent for the detection of myocardial …

[PDF][PDF] Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol

D Jain, J Frans, J Mattera, M McMahon… - Journal of Nuclear …, 1993 - Soc Nuclear Med
RESULTS All 20 patients in the study group had good quality im ages suitable for clinical
interpretation, as well as for anal ysis of kinetics. Specifically, there was no interpretative …

[PDF][PDF] Technetium-99m-1, 2-bis [bis (2-ethoxyethyl) phosphino] ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent

B Higley, FW Smith, T Smith, HG Gemmell… - Journal of Nuclear …, 1993 - Soc Nuclear Med
Pharmaceuticals R&D, Amersham Internationalpic, Amersham, Buckinghamshire, UK;
Department ofNuclear Medicine, Aberdeen Royal Infirmary, Forester/till, Aberdeen, UK; and …

Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease

BS Sridhara, S Braat, P Rigo, R Itti, P Cload… - The American journal of …, 1993 - Elsevier
Abstract Technetium-99m (To-99m) tetrofosmin, a new myocardial perfusion imaging agent,
was evaluated at exercise and rest in 50 patients with documented coronary artery disease …

Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease

G Munch, J Neverve, I Matsunari… - The Journal of …, 1997 - search.proquest.com
Subjects and Patients with Coronary Artery Disease Page 1 Myocardial Technetium-99m-Tetrofosmin
and Technetium-99m-Sestamibi Kinetics in Normal Subjects and Patients with Coronary Artery …

Physiological basis of myocardial perfusion imaging with the technetium 99m agents

GA Beller, DD Watson - Seminars in nuclear medicine, 1991 - Elsevier
In recent years, several technetium 99m-labeled myocardial perfusion agents have been
under investigation to determine their utility in assessing regional myocardial blood flow and …